Abstract
Background
Subglottic squamous cell carcinoma (SCC) represents less than 5% of all laryngeal cancers. Our objective was to better characterize survival using the National Cancer Database (NCDB) registry from 2004 to 2015.
Results
403 patients met inclusion criteria. 63.8% presented with advanced-stage disease. Treatment regimens were as follows: 15.9% underwent surgery alone, 16.9% underwent surgery followed by adjuvant therapy, and 67.2% underwent primary chemo/radiation (C/RT). Five-year overall survival (OS) was 58.6% for Stage I and II patients, 49.1% for Stage III, and 36.3% for stage IV. Adjusted OS for all-stage patients was worse with C/RT compared to upfront surgery (40.6% vs. 58.4%; HR 1.83 [95%CI 1.29–2.61] p < 0.001) and adjusted OS for stage 4 disease was significantly worse with C/RT compared to surgery (26.0% vs. 45.2%, HR 1.79 [95%CI 1.17–2.73] p = 0.007).
Conclusion
Majority of patients were treated with primary C/RT. Adjusted survival favors upfront surgery versus C/RT, especially in patients with Stage IV disease.
Similar content being viewed by others
References
Coskun H, Mendenhall WM, Rinaldo A et al (2019) Prognosis of subglottic carcinoma: is it really worse? Head Neck 41(2):511–521
Santoro R, Turelli M, Polli G (2000) Primary carcinoma of the subglottic larynx. Eur Arch Otorhinolaryngol 257:548–551
Landry D, Glastonbury CM (2015) Squamous cell carcinoma of the upper aerodigestive tract: a review. RadiolClin North Am 53(1):81–97
Smee RI, Williams JR, Bridger GP (2008) The management dilemmas of invasive subglottic carcinoma. ClinOncol (R CollRadiol) 20(10):751–756
MacNeil SD, Patel K, Liu K et al (2018) Survival of patients with subglottic squamous cell carcinoma. CurrOncol 25(6):e569–e575
Marchiano E, Patel DM, Patel TD et al (2016) Subglottic squamous cell carcinoma: a population-based study of 889 cases. Otolaryngol Head Neck Surg 154(2):315–321
National Comprehensive Cancer Network (2019) NCCN clinical practice guidelines in oncology in Head and neck cancers. http://www.nccn.org/professionals/physician_gls/pdf/head-and-neck.pdf
Department of Veterans Affairs Laryngeal Cancer Study G, Wolf GT, Fisher SG, et al (1991) Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 324(24):1685–1690
Mohanty S, Bilimoria KY (2014) Comparing national cancer registries: The National Cancer Data Base (NCDB) and the surveillance, epidemiology, and end results (SEER) program. J SurgOncol 109(7):629–630
Garas J, McGuirt WF Sr (2006) Squamous cell carcinoma of the subglottis. Am J Otolaryngol 27(1):1–4
Shaha AR, Shah JP (1982) Carcinoma of the subglottic larynx. Am J Surg 144(4):456–458. https://doi.org/10.1016/0002-9610(82)90422-6
Lyhne NM, Johansen J, Kristensen CA et al (2016) Incidence of and survival after glottic squamous cell carcinoma in Denmark from 1971 to 2011-A report from the Danish Head and Neck Cancer Group. Eur J Cancer 59:46–56
Baird BJ, Sung CK, Beadle BM, Divi V (2018) Treatment of early-stage laryngeal cancer: A comparison of treatment options. Oral Oncol 87:8–16
Chen JJ, Stessin A, Christos P, Wernicke AG, Nori D, Parashar B (2015) Differences in survival outcome between stage I and stage II glottic cancer: A SEER-based analysis. Laryngoscope 125(9):2093–2098
Pfister DG, Laurie SA, Weinstein GS et al (2006) American Society of Clinical Oncology clinical practice guideline for the use of larynx-preservation strategies in the treatment of laryngeal cancer. J ClinOncol 24(22):3693–3704
Chen MM, Roman SA, Yarbrough WG, Burtness BA, Sosa JA, Judson BL (2014) Trends and variations in the use of adjuvant therapy for patients with head and neck cancer. Cancer 120(21):3353–3360
Dahm JD, Sessions DG, Paniello RC, Harvey J (1998) Primary subglottic cancer. Laryngoscope 108(5):741–746
Guedea F, Parsons JT, Mendenhall WM, Million RR, Stringer SP, Cassisi NJ (1991) Primary subglottic cancer: results of radical radiation therapy. Int J RadiatOncolBiolPhys 21(6):1607–1611
Hata M, Taguchi T, Koike I et al (2013) Efficacy and toxicity of (chemo)radiotherapy for primary subglottic cancer. Strahlentherapie und Onkologie Organ der DeutschenRontgengesellschaft [et al] 189(1):26–32
Haylock BJ, Deutsch GP (1993) Primary radiotherapy for subglottic carcinoma. ClinOncol 5(3):143–146
Paisley S, Warde PR, O’Sullivan B et al (2002) Results of radiotherapy for primary subglottic squamous cell carcinoma. Int J RadiatOncolBiolPhys 52(5):1245–1250
Strome SE, Robey TC, Devaney KO, Krause CJ, Hogikyan ND (1999) Subglottic carcinoma: review of a series and characterization of its patterns of spread. Ear Nose Throat J 78(8):622–624, 626, 628, passim
Vermund H (1970) Role of radiotherapy in cancer of the larynx as related to the TNM system of staging. A review. Cancer 25(3):485–504
Warde P, Harwood A, Keane T (1987) Carcinoma of the subglottis. Results of initial radical radiation. Arch Otolaryngol Head Neck Surg 113(11):1228–1229
Author information
Authors and Affiliations
Contributions
The NCDB is a joint project of the Commission on Cancer of the American College of Surgeons and the American Cancer Society. The data used in the study are derived from a de-identified NCDB file. The American College of Surgeons and the Commission on Cancer have not verified and are not responsible for the analytic or statistical methodology employed, or the conclusions drawn from these data by the investigator.
Corresponding author
Ethics declarations
Conflicts of interest
None to disclose.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Shi, L.L., McMullen, C., Vorwald, K. et al. Survival outcomes of patients with subglottic squamous cell carcinoma : a study of the National Cancer Database. Eur Arch Otorhinolaryngol 278, 4923–4932 (2021). https://doi.org/10.1007/s00405-021-06712-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-021-06712-w